nach oben

Erschienen in:

01.12.2014 | case report

Liver abscess following radioembolization with yttrium-90 microspheres

verfasst von: Assist. Prof. Dr. Mehmet Korkmaz, MD, Halil Bozkaya, MD, Celal Çınar, MD, Bekir Şanal, MD, Serkan Güneyli, MD, Mustafa Parıldar, MD, İsmail Oran, MD

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 23-24/2014

Einloggen, um Zugang zu erhalten

Summary

Radioembolization with yttrium-90 microspheres is an accepted and useful intervention model with minimal invasion in both primary and secondary liver malignancies. Radioembolization may lead to some complications. Liver abscess is a rare complication that can occur several weeks after radioembolization treatment of liver tumor with yttrium-90 microspheres. There are only a few case reports on hepatic liver abscess observed in early term of radioembolization treatment, and our case also constitutes a rare report that may contribute to the possible future improvements in radioembolization field to get more insight into the current understanding of the formation of some deleterious insults such as hepatic abscess.

Vorheriger Artikel Postoperative immunosuppression markers and the occurrence of sepsis in patients with benign and malignant disease

Nächster Artikel A severe case of esophageal ulcer causing a tight stricture despite long-term D-penicillamine treatment

Salem R, Lewandowski RJ, Mulcahy MF, Riaz A, Ryu RK, Ibrahim S, et al. Radioembolization for hepatocellular carcinoma using yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology. 2010;138:52–64.PubMedCrossRef

Atassi B, Bangash AK, Lewandowski RJ, Ibrahim S, Kulik L, Mulcahy MF, et al. Biliary sequelae following radioembolization with yttrium-90 microspheres. J Vasc Interv Radiol. 2008;19:691–7.PubMedCrossRef

Mascarenhas NB, Mulcahy MF, Lewandowski RJ, Salem R, Ryu RK. Hepatic abscess after yttrium-90 radioembolization for islet-cell tumor hepatic metastasis. Cardiovasc Intervent Radiol. 2010;33:650–3.PubMedCrossRef

Kim W, Clark TWI, Baum RA, Soulen MC. Risk factors for liver abscess formation after hepatic chemoembolization. J Vasc Interv Radiol. 2001;12:965–8.PubMedCrossRef

Georgiades CS, Hong K, Geschwind JF. Pre- and postoperative clinical care of patients undergoing interventional oncology procedures: a comprehensive approach to preventing and mitigating complications. Tech Vasc Interv Radiol. 2006;9:113–4.PubMedCrossRef

Cholapranee A, Soulen MC. Risk of liver abscess following Y-90 radioembolization in patients with prior biliary intervention. J Vasc Interv Radiol. 2012;3:71.CrossRef

Salem R, Thurston KG. Radioembolization with 90 yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. J Vasc Interv Radiol. 2006;17:1425–39.PubMedCrossRef

Atassi B, Bangash AK, Bahrani A, Pizzi G, Lewandowski RJ, Ryu RK, et al. Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay. Radiographics. 2008;28:81–99.PubMedCrossRef

Johannsen EC, Sifri CD, Madoff LC. Pyogenic liver abscesses. Infect Dis Clin North Am. 2000;14:547–63.PubMedCrossRef

10.

Song SY, Chung JW, Han JK, Lim HG, Koh YH, Park JH, et al. Liver abscess after transcatheter oily chemoembolization for hepatic tumors: incidence, predisposing factors, and clinical outcome. J Vasc Interv Radiol. 2001;12:313–20.PubMedCrossRef

Titel: Liver abscess following radioembolization with yttrium-90 microspheres
verfasst von: Assist. Prof. Dr. Mehmet Korkmaz, MD
Halil Bozkaya, MD
Celal Çınar, MD
Bekir Şanal, MD
Serkan Güneyli, MD
Mustafa Parıldar, MD
İsmail Oran, MD
Publikationsdatum: 01.12.2014
Verlag: Springer Vienna
Erschienen in: Wiener klinische Wochenschrift / Ausgabe 23-24/2014
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI: https://doi.org/10.1007/s00508-014-0609-2

Springer Medizin Österreich

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 23-24/2014

Konsensus-Statement – Schlaganfallprophylaxe bei nicht-valvulärem Vorhofflimmern unter besonderer Berücksichtigung der direkten oralen Antikoagulanzien

Vorstand und Ausschuss der ÖGIM mit 1. Jänner 2015

Pneumocystis pneumonia (PCP) and Pneumocystis jirovecii carriage in renal transplantation patients: a single-centre experience

Mitteilungen der Gesellschaft der Ärzte in Wien

Can mean platelet volume be a novel predictive marker in patients with pelvic inflammatory disease?

Emergency (clonal spread) of methicillin-resistant Staphylococcus aureus (MRSA), extended spectrum (ESBL) – and AmpC beta-lactamase-producing Gram-negative bacteria infections at Pediatric Department, Bosnia and Herzegovina